ampicillin- ampicillin capsule
preferred pharmaceuticals inc. - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin capsules, usp are indicated in the treatment of infections caused by susceptible strains of the designated organism listed below: infections of the genitourinary tract including gonorrhea: e. coli, p. mirabilis, enterococci, shigella, s. typhosa and other salmonella , and nonpenicillinase producing n. gonorrhoeae . infections of the respiratory tract: nonpenicillinase- producing h. influenzae and staphylococci, and streptococci including streptococcus pneumoniae . infections of the gastrointestinal tract: shigella, s. typhosa and other salmonella, e. coli, p. mirabilis, and enterococci. meningitis: n. meningitides . to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin and other antibacterial drugs, ampicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibac
ampicillin capsule
bryant ranch prepack - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin capsules, ampicillin for oral suspension and other antibacterial drugs, ampicillin capsules and ampicillin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting of modifying antimicrobial therapy, in the absence of such data, local epidemiology and susceptibility patterns contribute to the empiric selection of therapy. ampicillin capsules and ampicillin for oral suspension are indicated in the treatment of infections caused by susceptible strains of the designated organisms listed below: infections of the genitourinary tract including gonorrhea - e. coli, p. mirabilis , enterococci, shigella, s. typhosa and other salmonella and nonpenicillinase-producing n. gonorrhoeae . infections of the respiratory tract - nonpenicillinase-producing
ampicillin capsule
remedyrepack inc. - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - ampicillin capsules, usp are indicated in the treatment of infections caused by susceptible strains of the designated organism listed below: infections of the genitourinary tract including gonorrhea: e. coli, p. mirabilis, enterococci, shigella, s. typhosa and other salmonella , and nonpenicillinase producing n. gonorrhoeae . infections of the respiratory tract: nonpenicillinase- producing h. influenzae and staphylococci, and streptococci including streptococcus pneumoniae . infections of the gastrointestinal tract: shigella, s. typhosa and other salmonella, e. coli, p. mirabilis, and enterococci. meningitis: n. meningitides . to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin and other antibacterial drugs, ampicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. bacteriology studies to determine the causative organisms and their susceptibility to ampicillin should be performed. therapy may be instituted prior to the results of susceptibility testing. a history of a previous hypersensitivity reaction to any of the penicillins is a contraindication. ampicillin is also contraindicated in infections caused by penicillinase-producing organisms.
ac mayhem 225 insecticide
axichem pty ltd - methomyl; methanol - liquid concentrate - methomyl carbamate-methylcarbamate active 225.0 g/l; methanol solvent other 593.0 g/l - insecticide
apo-ranitidine tablet 150mg
apotex inc - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists
apo-ranitidine tablet 300mg
apotex inc - ranitidine (ranitidine hydrochloride) - tablet - 300mg - ranitidine (ranitidine hydrochloride) 300mg - histamine h2-antagonists
ranitidine tablet
pro doc limitee - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists
ranitidine tablet
pro doc limitee - ranitidine (ranitidine hydrochloride) - tablet - 300mg - ranitidine (ranitidine hydrochloride) 300mg - histamine h2-antagonists
teva-ranitidine tablet
teva canada limited - ranitidine (ranitidine hydrochloride) - tablet - 300mg - ranitidine (ranitidine hydrochloride) 300mg - histamine h2-antagonists
teva-ranitidine tablet
teva canada limited - ranitidine (ranitidine hydrochloride) - tablet - 150mg - ranitidine (ranitidine hydrochloride) 150mg - histamine h2-antagonists